PharmStockPharmacy Stock

Nimotop
Nimotop

2.28
Used to address pain and inflammation, this generic medicine relaxes blood vessel walls to improve blood flow and tissue oxygenation.
Ingredient
Nimodipine
Category
Pain & Anti-Inflammatories
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Nimodipine
Reference Brand
Nimodipine
Product Origin
Generic Alternative
Reference Manufacturer
Bayer
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Dihydropyridine Calcium Channel Blocker
Pharmacological Class
Cerebral Vasodilator
Manufacturer Description
Designed to support cerebral arterial blood flow to manage neurological safety and alleviate local arterial spasm.
Mechanism of Action
Selectively blocks calcium channels in cerebral arterial walls, preventing arterial spasms and subsequent tissue ischemia.
Route of Administration
Oral
Onset Time
1 hour
Duration
4–6 hours
Contraindications
Concurrent use of strong CYP3A4 inhibitors
Severe Adverse Events
Severe cardiovascular collapse — requires immediate medical attention
Common Side Effects
Headache, Nausea, Dizziness
Uncommon Side Effects
Hypotension, Diarrhea, Flushing
Drug Interactions
Clarithromycin, Rifampin, Antihypertensives
Pregnancy Safety Warnings
TGA Category C: Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C. Protect from light.
Related Products
Calan
Information related to Nimotop is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Female Health Medication Australia - Clomiphene Fertility Treatment Tablet